GMABD31N/3pRNA complex

N/A

Report date: 2025/03/20 15:05:05

Base Information

Drug NameGMABD31N/3pRNA complex
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionRetinoic acid-inducible gene I stimulants
TargetsRetinoic acid-inducible gene I
Therapy Area/IndicationsMedulloblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesGennao BioYale University
Inactive CompaniesN/A
Active IndicationsMedulloblastoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A